Bonus BioGroup Cash Flow Statement

Financials in millions ILS. Fiscal year is January - December.

Millions ILS. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2016
Net Income	-24.49	-27.83	-28.53	-38.7	-90.08	Upgrade
Depreciation & Amortization	2.76	2.79	2.76	2.66	1.48	Upgrade
Loss (Gain) From Sale of Investments	-	-	-	7.9	20.98	Upgrade
Stock-Based Compensation	1.46	1.63	1.45	7.6	9.85	Upgrade
Other Operating Activities	0.07	-0.05	-0.75	-6.93	26.34	Upgrade
Change in Accounts Receivable	-0.69	0.13	0.35	0.36	-0.52	Upgrade
Change in Accounts Payable	1.05	-0.47	-0.38	-2.35	2.44	Upgrade
Change in Other Net Operating Assets	4.91	2.42	-1.3	0.64	-10.33	Upgrade
Operating Cash Flow	-14.93	-21.37	-26.4	-28.82	-39.84	Upgrade
Capital Expenditures	-0.01	-0.34	-0.82	-6.39	-5.81	Upgrade
Investment in Securities	-	13	-13.43	-	-	Upgrade
Other Investing Activities	-	-	-	0.1	-0.37	Upgrade
Investing Cash Flow	-0.01	12.65	-14.26	-6.29	-6.18	Upgrade
Long-Term Debt Repaid	-1.49	-1.3	-1.16	-1.2	-1.65	Upgrade
Total Debt Repaid	-1.49	-1.3	-1.16	-1.2	-1.65	Upgrade
Net Debt Issued (Repaid)	-1.49	-1.3	-1.16	-1.2	-1.65	Upgrade
Issuance of Common Stock	9.91	3.85	-	3.34	111.35	Upgrade
Other Financing Activities	-	-	-	-	3.72	Upgrade
Financing Cash Flow	8.42	2.55	-1.16	2.14	113.42	Upgrade
Foreign Exchange Rate Adjustments	-0.1	0.09	1.12	7.05	-3.94	Upgrade
Net Cash Flow	-6.63	-6.08	-40.69	-25.93	63.46	Upgrade
Free Cash Flow	-14.95	-21.72	-27.22	-35.2	-45.65	Upgrade
Free Cash Flow Per Share	-0.01	-0.02	-0.02	-0.03	-0.04	Upgrade
Cash Interest Paid	0.72	0.8	0.86	0.9	0.34	Upgrade
Levered Free Cash Flow	-6.32	-11.84	-17.26	-20.47	-44.15	Upgrade
Unlevered Free Cash Flow	-5.88	-11.35	-16.73	-19.91	-43.8	Upgrade
Change in Working Capital	5.27	2.08	-1.33	-1.35	-8.41	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.